1/41
Looks like no tags are added yet.
Which of the following statements are true regarding single bolus IV two-compartment? SATA
-The CENTRAL COMPARTMENT contains blood and highly perfused tissue
-Drug equilibrates instantaneously with all of tissues associated with central compartment
-A drug can reach different equilibrium concentration in different tissue within CENTRAL COMPARTMENT (i.e., some tissues can have higher affinity than other)
-For most drugs, elimination only occurs from the CENTRAL COMPARTMENT
-Liver and kidney are highly perfused and often considered part of the CENTRAL COMPARTMENT
Absorption is a passage of drug molecules from the administration site into circulation
True
An oral hypoglycemic is administered once to a patient in whom it has a half-life of 36hr. The dose is 250 mg, and it is completely absorbed. What is the daily average Steady state In patients receiving 25 mg three times daily?
540-542
Single oral dose of 50 mg indomethacin in patients with rheumatoid arthritis gave rise to an AUC of 6.1 mg.hr/L and half-life of 2.3 he. What is the daily average Steady state plasma concentration (ug/L), In patients receiving 25 mg three times daily
381-383
A 60 kg patient received a single oral dose of 25 mg of an antibiotic which is completely absorbed after oral administration, Serial plasma samples were drawn, and they determined using a sensitive analytical method.
The plasma concentration follow the equation below: Cp =630 ( e-0.231*t -e-0.99)
Determine the volume of distribution (L) if this drug. Assume that the concentration are in ug/L and the first-order rate constants are in hr-1
49-54
(Extra Credit) Lipids soluble drugs have harder time moving across cell membranes?
False
Rifampin (unionized free base pKa 7.9) is a drug used to treat TB. The following date was collected following a 600 mg oral tablet from the innovator (treatment A) form a generic drug (treatment B) and a 400 mg IV dose (treatment C)
AUC ug0mL*hr. A=53.9, B=57.7, C+39.8
Cpmax (mg/L) A=10.6, B=9.9
Ka (hr-1) A=2.66, B=1.37, C= 0.0028
Kel (hr-1) =0.25
Calculate the comparative bioavailability for the generic drug
1.05
Area under the curve (AUC) is used to determine the effectiveness of a given drug after administration by a particular route.
True
A drug that follows a two-compartment pharmacokinetic model was given as a single IV bolus dose of 5.6 mg/kg. The equation that describes the plasma concentration -time (hr.) data is: CP (mg/L) = 18e -2.8t + e -0.11t
What will be the equation that describes the plasma concentration -time profile if the dose was given as 2.8 mg/kg?
Cp = 9 e-2.8t + 3 e-0.11t
A drug that follows a two-compartment model was given as a single IV bolus dose of 50-mg. The equation that describes the plasma concentration-time
Cp=1.3 e -0115t + 0.4 e -0.0067t
What will be plasma concentration when 95% of the administrated dose is eliminated ( mg/L)
a. 0.0237
0.0237
In multiple IV dosing, average plasma concentration (Cpss) is equal to Dose / (CL x tau): where CL = clearance
True
In multiple dosing concentration fluctuate between a maximum concentration (Cpss max) and a minimum concentration (CSS min) at steady state.
True
A drug that follows a multicompartment model is given to a patient by rapid IV injection. Would the drug concentration in each tissue be the same after the drug equilibrates with the plasma and the tissue in the body?
No because drugs usually have different affinities to different tissues depending on their physicochemical properties
Which of the following best defines clinical pharmacokinetics?
Application pf Pharmacokinetics in patient's drug therapy management
If fixed-dose regimen is repeatedly given, the drug will accumulate in the body until steady state is reached, after which the ratio of drug administered is equal to rate of drug eliminated.
True
After IV administration of sodium warfarin, 1.5 mg/kg to an adult subject the following pharmacokinetic parameters were obtained half-life 2.3 days. Initial plasma concentration (Cpo) is 15 mg/L. the adult weights 70 kg. Oral maintenance dose was continued with a daily doses 20 mg. what would be the average concentration (mg/L) of warfarin in the plasma at steady state if the drug bioavailability is 100%. Answer must be numeric and round off final answer to the nearest whole number.
8-10
Which of the following statements are true regarding single bolus IV two-compartment model. SATA
Drug is initially added to the central compartment.
Drug is removed from the central compartment by both clearance, and distribution to the peripheral compartment.
Drug is transferred between the central and peripheral compartments
Rifampin (unionized free base pKa 7.9) is a drug used to treat TB. The following date was collected following a 600 mg oral tablet from the innovator (treatment A) form a generic drug (treatment B) and a 400 mg IV dose (treatment C)
AUC ug0mL*hr. A=53.9, B=57.7, C+39.8
Cpmax (mg/L) A=10.6, B=9.9
Ka (hr-1) A=2.66, B=1.37, C= 0.0028
Kel (hr-1) =0.25
What is the volume of distribution of Rifampin (L)
40
Which of the following are application of pharmacokinetic drug modeling? SATA
To relate temporal pattens of response (Efficacy, harm) to drug administration following acute and chronic
to help provide a rational basic for drug design, drug selection, and drug regiment design
To help quantitatively evaluate drug product performance in vivo and establish in vitro dissolution protocols
To provide a means for rationally initiating and individualizing drug administration in patients
Rifampin (unionized free base pKa 7.9) is a drug used to treat TB. The following date was collected following a 600 mg oral tablet from the innovator (treatment A) form a generic drug (treatment B) and a 400 mg IV dose (treatment C)
AUC ug0mL*hr A=53.9, B=57.7, C+39.8
Cpmax (mg/L) A=10.6, B=9.9
Ka (hr-1) A=2.66, B=1.37, C= 0.0028
Kel (hr-1) =0.25
Calculate the absolute bioavailability for the generic product
1
A patient receives amoxicillin (Amoxil) to treat strep throat. Amoxil was administrated as intravenous injection. Its volume of distribution of 25 L, half-life is 4.62 hours, and the maximum and minimum plasma concentrations were 34.3 Mg/L and 10.3 mg/L respectively. What would be the suitable dosing interval for this antibiotic
8
Compartments PK model, the plasma -drug level curve declines more slowly in the beta phase. Because of redistribution of drug out of the tissue compartmented. Hence beta is smaller the K; thus is a true elimination constant, whereas beta is a hybrid elimination rate constant that is influenced by the rate of transfer if the rate of transfer of drug in and out of the tissue compartment.
True
Valproate is a carboxylic acid anticonvulsant, at least in part, to increase concentrations of the neurotransmitter inhibitor gamma amniocytic acid in the blood used alone or is combination with other anticonvulsants in the prophylactic management of petit mall. It appears to be almost entirely cleared by liver function with negligible amounts into urine unchanged. It comes as soft gelatin capsules of 250 mg and enteric coated tablets 250 and 500 mg as well as oral syrup of 250 mg/ 500.
Two different formulations of Valproate (250mg) were prepared by Pfizer. The data is as follows:
Formulation A
AUC = 287 mg/L*hr
Ka=0.7 hr-1
Kel =0.064 hr-1
Formulation B
AUC =243.36 mg/L*hr
Cpmax =11.7 mg/L
Ka =0.493 hr-1
Kel= 0.0655 hr-1
Five hundred mg of valproate was administered by IV bolus. The AUC for that route was 574 mg/L*hr
Find the Cpmax for formulations A Mg/L
14.6
From the graph below, what is the average plasma concentration (in mg/L) at steady state? .
65
The following dosing regimen have the same dosing rate.
a. 100 mg q 4 hr.
b. 150 mg q 6 hr.
c. 200 mg q 8 hr.
d. 300 mg q 12 hr.
True
Rifampin (unionized free base pKa 7.9) is a drug used to treat TB. The following date was collected following a 600 mg oral tablet from the innovator (treatment A) form a generic drug (treatment B) and a 400 mg IV dose (treatment C)
AUC ug0mL*hr A=53.9, B=57.7, C+39.8
Cpmax (mg/L) A=10.6, B=9.9
Ka (hr-1) A=2.66, B=1.37, C= 0.0028
Kel (hr-1) =0.25
What is the Cpo for C ( mg/L)
10
When a 600 mg of antibiotic is administered intravenously as a bolus dose, plasma concentration of 8.1 mg/L is achieved (Cp0). The half-life of this drug 3 hours. If dose of 600 mg were administered every 8 hours for several days, what will be the maximum plasma concentration (mg/L) of this antibiotic
9.6
If fixed dose regimen is repeatedly given, the drug will accumulate in the body steady state is reached, after which the rate of drug administered is equal to rate of drug eliminated.
True
Because we cannot practically measure drug concentration in specific tissues, we measure it in the plasma and assume that this concentration is related to the tissue concentration volume of distribution.
True
(Extra credit) A 72.3 kg patient is to receive sulfasalazine for urinary tract infection. Sulfasalazine is a rapidly and completely absorbed after oral administration. Its volume of di_____ L/kg and half-life is 6.3 hr. What would be the maintenance dose (mg) necessary to maintain an average steady state plasma concentration of 140 mg/L if the patient receives a ___ hours ?
1000
33. A 75 kg patient is receive Cephalexin (Keflex) for urinary tract infection. Cephalexin (Keflex) is a rapidly and completely absorbed after oral administration. Its volume of distribution is __ L/kg and half-life is 6.3 hr. what oral loading dose (mg) would you recommend to rapidly achieve plasma concentration at 120 mg/L?
900
In multiple dosing, the maximum concentration (Cp,,min) is the same after each dose as is the minimum concentration (Cp,,min) at steady state:
True
For a drug with characteristics of a 2-compartment IV bolus injection model in the elimination phase, what process dominates the concentration-time-profile?
Elimination
Therapeutic drug concentration monitoring with plasma concentration data assumes that pharmacologic response is related to the drug concentration in plasma?
True
Which of the following assumptions of a two-compartment model are true? SATA
The body contains 2 compartments, central and peripheral
All kinetics are first order
Elimination is from the central compartment
Changes in plasma drug concentration reflect quantitively the change in tissue drug concentration in the body.
It is a linear pharmacokinetic
In a single bolus Iv administration if the Ln plasma concentration (Cp( versus time (t) graph does not show the break in the break in the curve, could the drug still have characteristics of a 2- compartment model
False
A drug has a distribution that can be described by a two-compartment open model. If the drug is given by IV bolus: Which of the following statements is incorrect?
None of the above
For a drug with characteristics of a 2-compartment IV bolus injection model in the distribution phase, what process dominates the concentration-time-profile?
Distribution
A single oral dose 100 mg of an antibiotic was given to an adult male patient. The equation that describe the plasma concentration-time profile is:
Cp = 45 ( e-0.17t - e-1.5t )
Determine the Cpmax (mg/L) for the drug in this patient. Assume that the concentrations are in mg/L and the first-order rate consists are in hr-1
29-32
Which of the following is true regarding multiple dosing? SATA
There is a fixed time interval between each dose
Fixed time interval is called tau
200 mg every 4 hours, tau = 4 hours
Tau is interval of dose or dosing interval
Matejko and Ogilvie (1973) demonstrated that theophylline followed a two-compartment pharmacokinetic model in human subjects. After administering a single intravenous dose (5.6 mg/kg) in nine normal volunteers, these investigators demonstrated that the equation best describing theophylline kinetics in humans was as follows: Cp=12e-5.8t + 18e-0.16t .
What is the plasma level of the drug 24 hours after the IV dose (Cp24 (mg/L))?
0.3868
Valproate is a carboxylic acid anticonvulsant, at least in part, to increase concentrations of the neurotransmitter inhibitor gamma amniocytic acid in the blood used alone or is combination with other anticonvulsants in the prophylactic management of petit mall. It appears to be almost entirely cleared by liver function with negligible amounts into urine unchanged. It comes as soft gelatin capsules of 250 mg and enteric coated tablets 250 and 500 mg as well as oral syrup of 250 mg/ 500.
Two different formulations of Valproate (250mg) were prepared by Pfizer. The data is as follows:
Formulation A
AUC = 287 mg/L*hr
Ka=0.7 hr-1
Kel =0.064 hr-1
Formulation B
AUC =243.36 mg/L*hr
Cpmax =11.7 mg/L
Ka =0.493 hr-1
Kel= 0.0655 hr-1
Five hundred mg of valproate was administered by IV bolus. The AUC for that route was 574 mg/L*hr
Calculate the total Body Clearance (TBC) of valproate formulation A (L/hr
0.9